IMMUNITYBIO, INC. Accounts Payable
IMMUNITYBIO, INC. (IBRX) had Accounts Payable of $33.57 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-05-11
- 2023-03-31: Accounts Payable, Current $33.57M.
- 2022-12-31: Accounts Payable, Current $21.02M.
- 2022-09-30: Accounts Payable, Current $20.24M.
- 2022-06-30: Accounts Payable, Current $18.05M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2023-03-31 | $33.57M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $21.02M 10-Q · filed 2023-05-11 | |
| 2022-09-30 | $20.24M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $18.05M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $9.83M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $11.42M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $15.12M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $19.15M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $20.10M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $11.51M 10-K · filed 2022-03-01 | $4.10M 10-K · filed 2021-03-04 |
| 2020-09-30 | $6.16M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.97M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.15M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $8.80M 8-K/A · filed 2021-04-22 | $1.75M 10-K · filed 2020-03-25 |
| 2019-09-30 | $2.12M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.93M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.80M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $2.79M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $3.52M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $5.50M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $3.57M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $5.87M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $9.48M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $4.27M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $4.28M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $4.04M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $2.25M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $3.30M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.10M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $2.08M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $4.95M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $3.18M 10-Q · filed 2015-09-10 | |
| 2014-12-31 | $1.13M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |